Large-scale SPPS capacity in Braine-l’Alleud starts production
See media releaseInnovation for large-scale peptide production
See our presentation at a recent broker event related to GLP-1
Download presentationCreating the future in peptides
We lead innovation in peptide API’s to the benefit of millions of patients
Contact usAhead on green peptide chemistry
Together we improve process performance while reducing the environmental footprint
Learn moreMarket leader in peptide API manufacturing and services
PolyPeptide is a Contract Development & Manufacturing Organization (CDMO) supporting pharmaceutical and biotech companies in the development and manufacturing of proprietary and generic active pharmaceutical ingredients (API).
PolyPeptide announces results of the annual General Meeting 2025
9 Apr 2025 - Baar, 9 April 2025 – PolyPeptide Group AG (SIX: PPGN), a specialized global CDMO for peptide-based active pharmaceutical ingredients, today announced that the shareholders approved all […]
Read moreExpanding the Reach of Sustainable Solid-Phase Peptide Synthesis
2 Apr 2025 - Alloc protecting group expanded the peptide synthesis toolbox. Its removal can sometimes be seen as an issue: toxic solvents, air-sensitive Pd0) reagents, challenging upscaling. Not anymore […]
Read more